The wider TRIUMPH program (8 Phase 3 trials) TRIUMPH-4 is one of eight Phase 3 trials in the TRIUMPH program
Studies show thymosin beta-4 accelerates wound healing by increasing reepithelialization by 42% at 4 days and 61% at 7 days post-injury, with treated wounds also contracting at least 11% more than controls
None of this means the product lacks utility
Until rigorous, randomized, placebo-controlled trials are conducted and published, the responsible position is to rely on proven, evidence-based approaches to recovery and healing, and to leave unapproved peptides where they belong for now: in the laboratory, not in your body.
It accelerates the recovery of muscles, ligaments, tendons, and nerves by stimulating collagen production and promoting fibroblast activity